FR2439199A1 - Pyrido(2,1-b)quinazolones et medicaments qui en contiennent - Google Patents
Pyrido(2,1-b)quinazolones et medicaments qui en contiennentInfo
- Publication number
- FR2439199A1 FR2439199A1 FR7925883A FR7925883A FR2439199A1 FR 2439199 A1 FR2439199 A1 FR 2439199A1 FR 7925883 A FR7925883 A FR 7925883A FR 7925883 A FR7925883 A FR 7925883A FR 2439199 A1 FR2439199 A1 FR 2439199A1
- Authority
- FR
- France
- Prior art keywords
- methylthio
- methylsylsulfinulyfon
- quinazolones
- pyrido
- products containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229940126601 medicinal product Drugs 0.000 title 1
- QSLPNSWXUQHVLP-UHFFFAOYSA-N $l^{1}-sulfanylmethane Chemical class [S]C QSLPNSWXUQHVLP-UHFFFAOYSA-N 0.000 abstract 6
- -1 CYANO, HYDROXY-AMINOCARBONYL Chemical group 0.000 abstract 3
- 150000003254 radicals Chemical class 0.000 abstract 2
- KKFDJZZADQONDE-UHFFFAOYSA-N (hydridonitrato)hydroxidocarbon(.) Chemical group O[C]=N KKFDJZZADQONDE-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical group [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 125000003178 carboxy group Chemical class [H]OC(*)=O 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical group [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19782845766 DE2845766A1 (de) | 1978-10-18 | 1978-10-18 | Pyrido eckige klammer auf 2,1-b eckige klammer zu -chinazolinon-derivate, ihre herstellung und verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR2439199A1 true FR2439199A1 (fr) | 1980-05-16 |
Family
ID=6052696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7925883A Withdrawn FR2439199A1 (fr) | 1978-10-18 | 1979-10-18 | Pyrido(2,1-b)quinazolones et medicaments qui en contiennent |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4457927A (enExample) |
| EP (1) | EP0011142B1 (enExample) |
| JP (1) | JPS5557588A (enExample) |
| AT (1) | ATE2146T1 (enExample) |
| AU (1) | AU529643B2 (enExample) |
| CA (1) | CA1130805A (enExample) |
| CS (1) | CS216512B2 (enExample) |
| DD (1) | DD147242A5 (enExample) |
| DE (2) | DE2845766A1 (enExample) |
| DK (1) | DK154297C (enExample) |
| EG (1) | EG14028A (enExample) |
| ES (1) | ES485162A0 (enExample) |
| FI (1) | FI793229A7 (enExample) |
| FR (1) | FR2439199A1 (enExample) |
| GB (1) | GB2034705B (enExample) |
| GR (1) | GR73819B (enExample) |
| IE (1) | IE48852B1 (enExample) |
| IL (1) | IL58474A0 (enExample) |
| NO (1) | NO793344L (enExample) |
| NZ (1) | NZ191828A (enExample) |
| PL (3) | PL119174B1 (enExample) |
| PT (1) | PT70329A (enExample) |
| RO (1) | RO78339A (enExample) |
| SU (1) | SU1001857A3 (enExample) |
| ZA (1) | ZA795559B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3300477A1 (de) * | 1983-01-08 | 1984-07-12 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue heterocyclische verbindungen, ihre herstellung und verwendung |
| US4587339A (en) * | 1983-10-14 | 1986-05-06 | Sun Chemical Corporation | Nickel complex pigments of bis-azomethines |
| EP0597956A1 (en) * | 1991-07-29 | 1994-05-25 | Warner-Lambert Company | Quinazoline derivatives as acetylcholinesterase inhibitors |
| CA2238283C (en) * | 1997-05-30 | 2002-08-20 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions |
| US5858694A (en) * | 1997-05-30 | 1999-01-12 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of cancerous lesions |
| US6410584B1 (en) * | 1998-01-14 | 2002-06-25 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells with indole derivatives |
| US6200771B1 (en) | 1998-10-15 | 2001-03-13 | Cell Pathways, Inc. | Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia |
| US6130053A (en) * | 1999-08-03 | 2000-10-10 | Cell Pathways, Inc. | Method for selecting compounds for inhibition of neoplastic lesions |
| US6133271A (en) * | 1998-11-19 | 2000-10-17 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives |
| US6187779B1 (en) | 1998-11-20 | 2001-02-13 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives |
| US6369092B1 (en) | 1998-11-23 | 2002-04-09 | Cell Pathways, Inc. | Method for treating neoplasia by exposure to substituted benzimidazole derivatives |
| US6077842A (en) * | 1998-11-24 | 2000-06-20 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives |
| US6034099A (en) * | 1998-11-24 | 2000-03-07 | Cell Pathways, Inc. | Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones |
| US6486155B1 (en) | 1998-11-24 | 2002-11-26 | Cell Pathways Inc | Method of inhibiting neoplastic cells with isoquinoline derivatives |
| US6025394A (en) | 1999-01-29 | 2000-02-15 | Cell Pathways, Inc. | Method for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcohols |
| US6020379A (en) * | 1999-02-19 | 2000-02-01 | Cell Pathways, Inc. | Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia |
| US6555547B1 (en) | 2000-02-28 | 2003-04-29 | Cell Pathways, Inc. | Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative |
| US6569638B1 (en) | 2000-03-03 | 2003-05-27 | Cell Pathways, Inc | Method for screening compounds for the treatment of neoplasia |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1064259A (en) * | 1963-12-19 | 1967-04-05 | Union Pharma Scient Appl | New derivatives of 2-anilino-nicotinic acid and process for their preparation |
| US4033961A (en) * | 1975-10-07 | 1977-07-05 | Warner-Lambert Company | Pyrido[2-1-b]quinazolin-ones and their methods of preparation |
| DE2557425C2 (de) * | 1975-12-19 | 1987-03-19 | C.H. Boehringer Sohn, 6507 Ingelheim | 11-Oxo-11-H-pyrido[2,1-b]-chinazolin-2-carbonsäure und ihre Salze, Verfahren zu ihrer Herstellung und Arzneimittel |
| US4066767A (en) * | 1976-11-01 | 1978-01-03 | Warner-Lambert Company | 8-(1H-Tetrazol-5-yl)-11H-pyrido[2,1-b]quinazolin-11-ones and method of treating bronchial asthma using them |
| ES468127A1 (es) * | 1977-03-24 | 1979-09-16 | Hoffmann La Roche | Un procedimiento para la preparacion de nuevos derivados de pirido (2,1-b) quinazolina |
-
1978
- 1978-10-18 DE DE19782845766 patent/DE2845766A1/de not_active Withdrawn
-
1979
- 1979-10-11 NZ NZ191828A patent/NZ191828A/xx unknown
- 1979-10-15 EP EP79103974A patent/EP0011142B1/de not_active Expired
- 1979-10-15 AT AT79103974T patent/ATE2146T1/de not_active IP Right Cessation
- 1979-10-15 DD DD79216232A patent/DD147242A5/de unknown
- 1979-10-15 DE DE7979103974T patent/DE2964431D1/de not_active Expired
- 1979-10-16 GR GR60275A patent/GR73819B/el unknown
- 1979-10-16 PL PL1979218993A patent/PL119174B1/pl unknown
- 1979-10-16 AU AU51832/79A patent/AU529643B2/en not_active Expired - Fee Related
- 1979-10-16 RO RO7998984A patent/RO78339A/ro unknown
- 1979-10-16 PL PL1979227124A patent/PL123430B1/pl unknown
- 1979-10-16 PL PL1979227126A patent/PL123075B1/pl unknown
- 1979-10-17 NO NO793344A patent/NO793344L/no unknown
- 1979-10-17 CA CA337,796A patent/CA1130805A/en not_active Expired
- 1979-10-17 IE IE1969/79A patent/IE48852B1/en unknown
- 1979-10-17 DK DK438379A patent/DK154297C/da active
- 1979-10-17 SU SU792832051A patent/SU1001857A3/ru active
- 1979-10-17 IL IL58474A patent/IL58474A0/xx unknown
- 1979-10-17 PT PT70329A patent/PT70329A/pt unknown
- 1979-10-18 CS CS797083A patent/CS216512B2/cs unknown
- 1979-10-18 ZA ZA00795559A patent/ZA795559B/xx unknown
- 1979-10-18 EG EG624/79A patent/EG14028A/xx active
- 1979-10-18 ES ES485162A patent/ES485162A0/es active Granted
- 1979-10-18 GB GB7936147A patent/GB2034705B/en not_active Expired
- 1979-10-18 FR FR7925883A patent/FR2439199A1/fr not_active Withdrawn
- 1979-10-18 JP JP13363479A patent/JPS5557588A/ja active Granted
- 1979-10-18 FI FI793229A patent/FI793229A7/fi not_active Application Discontinuation
-
1982
- 1982-12-22 US US06/452,009 patent/US4457927A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2429593A1 (fr) | Medicaments contenant des derives d'imidazole | |
| FR2439182A1 (fr) | Nouveaux derives cyclopeptidiques, leur preparation et leur application comme medicaments | |
| FR2430410A1 (fr) | Phenethanolamines et compositions pharmaceutiques en contenant | |
| FR2361901A1 (fr) | Derives de substitution de nucleotides et medicament contenant ces substances | |
| SE7704256L (sv) | Nya substituerade fluoracylresorcin for lekemedel, kosmetika och pesticider samt forfarande for framstellning derav | |
| ES2038270T3 (es) | Preparaciones topicas sebosupresoras. | |
| FR2433512A1 (fr) | Derives de l'indane et medicaments qui en contiennent | |
| FR2398732A1 (fr) | Nouveau sel d'aluminium soufre, son procede de preparation et compositions cosmetiques et pharmaceutiques le contenant | |
| SE8000131L (sv) | Kompositioner for anvendning som kosmetiska medel samt ett forfarande for framstellning av de aktiva komponenterna deri | |
| FR2426682A1 (fr) | Derives de l'imidazole et medicaments qui en contiennent | |
| FR2374039A1 (fr) | Compositions contenant un derive de l'acide salicylique et applications a titre de medicament | |
| EP0271013A3 (en) | Basic substituted phenyl acetonitriles, their preparation and medicaments containing them | |
| FR2445329A1 (fr) | Derives du 11-bromo-14-oxo-15-hydroxy-imino-e-homo-eburnane, leur preparation et leur utilisation comme medicament | |
| FR2378026A1 (fr) | Medicaments contenant des derives de sulfure d'hydroxymethyl-2 amino-2' diphenyle | |
| AU530678B2 (en) | Phosphono-hydroxy-acetic acid | |
| ES527353A0 (es) | Procedimiento de preparacion de nuevos derivados de la nitrosourea | |
| FR2398069A1 (fr) | Nouvelles imidazo-isoquinoleine-diones, procedes pour leur preparation et leur utilisation en tant que medicaments | |
| NO166569C (no) | Fremgangsmaate til fremstilling av farmasoeytisk preparat inneholdende fosfolipider og ikke-steroidale antiflogistika. | |
| SE7909514L (sv) | Nya halofenyl-pyridyl-allylaminderivat | |
| FR2361387A1 (fr) | Composition dermatologique | |
| FR2393798A1 (fr) | Derives des tetrahydro-1,3,5-thiadiazine-4-one utilisables en tant que compositions insecticides et miticides | |
| SE7704255L (sv) | Fluoracylresorcininnehallande lekemedel, kosmetika och pesticider | |
| FR2433017A1 (fr) | Derives de la phtalazone-1 et medicaments qui en contiennent | |
| FR2438647A1 (fr) | Carbanilates d'alkylcarbonylamino-3 phenyles et produits herbicides qui en contiennent | |
| FR2399246A1 (fr) | Medicaments veterinaires antihelminthiques injectables a effet retard, a base de tetramisole |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |